AMS-18712-24856
2 vaccinations
1 coded response
25 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 511 / IA
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-24
Registered in v-safe
-
2021-02-24
Dose 1 — Pfizer-BioNTech
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-12
- 2021-03-17
- 2021-03-24
-
2021-03-25
Dose 2 — Pfizer-BioNTech
- 2021-03-25
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-03-27
Survey response — days 1–6 daily, dose 2MedDRA: Mood altered — Feeling: GoodFree text: MoodinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-03
- 2021-04-09
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-08
- 2021-09-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Pfizer-BioNTech | |
| 2 | 2021-03-25 | Pfizer-BioNTech |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Moodiness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Mood altered | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release